Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Financing Cash Flow

-$2.34B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Financing Cash Flow

Latest reported-$2.34Bperiod endingJun 30, 2026

Latest reported-$2.34Bperiod endingJun 30, 2026

REGN Quarterly Cash from Financing ($0.00 → -$2.34B)

Quarterly financing cash flow

High-resolution chart · PNG

REGN financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Financing Cash Flow — Quarterly (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2001	3,290,000
Mar 31, 2001	154,152,000
Dec 31, 2000	-161,000
Sep 30, 2000	17,555,000
Jun 30, 2000	72,798,000
Mar 31, 2000	2,675,000
Dec 31, 1999	200,000
Sep 30, 1999	-300,000
Jun 30, 1999	-200,000
Mar 31, 1999	600,000
Dec 31, 1998	-300,000
Sep 30, 1998	-300,000
Jun 30, 1998	-300,000
Mar 31, 1998	-500,000
Dec 31, 1997	-1,100,000
Sep 30, 1997	-700,000
Jun 30, 1997	42,200,000
Mar 31, 1997	-1,000,000
Dec 31, 1996	9,500,000
Sep 30, 1996	-900,000
Jun 30, 1996	57,500,000
Mar 31, 1996	200,000
Dec 31, 1995	21,800,000
Sep 30, 1995	-700,000
Jun 30, 1995	-700,000
Mar 31, 1995	-500,000
Dec 31, 1994	1,500,000
Sep 30, 1994	-700,000
Jun 30, 1994	-800,000
Mar 31, 1994	-200,000
Dec 31, 1993	-600,000
Sep 30, 1993	51,000,000
Jun 30, 1993	-300,000
Mar 31, 1993	-300,000
Dec 31, 1992	-200,000
Sep 30, 1992	-300,000
Jun 30, 1992	-200,000
Mar 31, 1992	-100,000
Dec 31, 1991	-100,000
Sep 30, 1991	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.